NGS and Prenatal Diagnostics Reshape Reproductive Genetics: Market Forecast 2025-2035 [Yahoo! Finance]
Illumina, Inc. (ILMN)
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
illumina.com/company/investor-information.html
Company Research
Source: Yahoo! Finance
Test Type, Application, Technology, End User, and Country-Level Analysis - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The market for genetic screening testing in reproductive health is expanding rapidly, driven by advances in technology, increased awareness of genetic conditions, and growing demand for personalized healthcare solutions. The genetic screening testing for reproductive health market includes a variety of tests, such as carrier screening, non-invasive prenatal testing (NIPT), and prenatal diagnostic tests. Carrier screening tests for conditions like cystic fibrosis, sickle cell anemia, and Tay-Sachs disease, while NIPT screens for chromosomal abnormalities such as Down syndrome and other genetic disorders. The market also involves diagnostic tests like amniocentesis and chorionic villus sampling (CVS), which are performed when a risk is identified during screening. Several factors contribute to the growth of the gen
Show less
Read more
Impact Snapshot
Event Time:
ILMN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ILMN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
News
- Illumina (NASDAQ:ILMN) had its price target raised by analysts at JPMorgan Chase & Co. from $105.00 to $130.00. They now have a "neutral" rating on the stock.MarketBeat
- Illumina (NASDAQ:ILMN) had its "underweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
- Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually [Yahoo! Finance]Yahoo! Finance
- Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion AnnuallyPR Newswire
ILMN
Earnings
- 10/30/25 - Beat
ILMN
Sec Filings
- 12/12/25 - Form 144
- 12/9/25 - Form 4
- 12/8/25 - Form 144
- ILMN's page on the SEC website